Related references
Note: Only part of the references are listed.A multicenter analysis of genomic profiles and PD-L1 expression of primary lymphoepithelioma-like carcinoma of the lung
Zhanhong Xie et al.
MODERN PATHOLOGY (2020)
Overcoming resistance to anti-PD-1 immunotherapy in lymphoepithelioma-like carcinoma: A case report and review of the literature
Zhengwu Tang et al.
LUNG CANCER (2020)
The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma
Shaodong Hong et al.
NATURE COMMUNICATIONS (2019)
EBV-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma Response to PD-L1 Blockade
Anand Narayanan et al.
CLINICAL LUNG CANCER (2019)
Clinical Features and Prognosis of Pulmonary Lymphoepithelioma-like Carcinoma: Summary of Eighty-five Cases
Yinyin Qin et al.
CLINICAL LUNG CANCER (2019)
Thorough survey and analysis of pulmonary lymphoepithelioma-like carcinoma in Macau and multimodality treatment for advanced disease
Na Zhou et al.
LUNG CANCER (2019)
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
Diego Chowell et al.
SCIENCE (2018)
Cytology cell blocks are suitable for immunohistochemical testing for PD-L1 in lung cancer
H. Wang et al.
ANNALS OF ONCOLOGY (2018)
Pulmonary Lymphoepithelioma-like Carcinoma Disguised as Squamous Cell Carcinoma
Ankit Anand et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Clinical Significance of Plasma Epstein-Barr Virus DNA in Pulmonary Lymphoepithelioma-like Carcinoma (LELC) Patients
Mian Xie et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Response of advanced stage recurrent lymphoepithelioma-like carcinoma to nivolumab
Vivek Kumar et al.
IMMUNOTHERAPY (2017)
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
Nicholas McGranahan et al.
CELL (2017)
PDL1 Regulation by p53 via miR-34
Maria Angelica Cortez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
PDL1 Regulation by p53 via miR-34
Maria Angelica Cortez et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer: the effect is autophagy-associated
Lei Yin et al.
TUMOR BIOLOGY (2016)
Surgical treatment for primary pulmonary lymphoepithelioma-like carcinoma
Zhichao Lin et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2016)
Clinicopathological features and prognosis of primary pulmonary lymphoepithelioma-like carcinoma
Wen-Yang Jiang et al.
JOURNAL OF THORACIC DISEASE (2016)
Classification of Advanced Human Cancers Based on Tumor Immunity in the MicroEnvironment (TIME) for Cancer Immunotherapy
Yu Zhang et al.
JAMA ONCOLOGY (2016)
Metastatic lymphoepithelioma-like carcinoma of the lung treated with nivolumab: a case report and focused review of literature
Chul Kim et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
A 65-Year-Old Man With Persistent Cough and Large Nodular Opacity
Brandon S. Grimes et al.
CHEST (2015)
PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy
Yih-Leong Chang et al.
LUNG CANCER (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Positive expression of programmed death ligand-1 correlates with superior outcomes and might be a therapeutic target in primary pulmonary lymphoepithelioma-like carcinoma
Li Jiang et al.
ONCOTARGETS AND THERAPY (2015)
PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survival
Wenfeng Fang et al.
ONCOTARGET (2015)
Treatment Outcomes of Patients With Different Subtypes of Large Cell Carcinoma of the Lung
Yung-Han Sun et al.
ANNALS OF THORACIC SURGERY (2014)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy
Wenfeng Fang et al.
ONCOTARGET (2014)
Lack of epidermal growth factor receptor gene mutations in exons 19 and 21 in primary lymphoepithelioma-like carcinoma of the lung
Qianwen Liu et al.
THORACIC CANCER (2014)
Computed tomography characteristics of primary pulmonary lymphoepithelioma-like carcinoma in 41 patients
Huali Ma et al.
EUROPEAN JOURNAL OF RADIOLOGY (2013)
Multimodality Treatment and Long-Term Follow-Up of the Primary Pulmonary Lymphoepithelioma-Like Carcinoma
Chung-Jen Huang et al.
CLINICAL LUNG CANCER (2012)
Unique p53 and epidermal growth factor receptor gene mutation status in 46 pulmonary lymphoepithelioma-like carcinomas
Yih-Leong Chang et al.
CANCER SCIENCE (2011)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Computed tomography characteristics of primary pulmonary lymphoepithelioma-like carcinoma
Chung-Jen Huang et al.
BRITISH JOURNAL OF RADIOLOGY (2007)
Chemoradiotherapy for advanced lymphoepithelioma-like carcinoma of the lung
JC Ho et al.
RESPIRATORY MEDICINE (2000)
Share Paper
